31 July 2024
Science in Sport plc
("Science in Sport", "the Company" or the "Group")
Result of Annual General Meeting
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, held its Annual General Meeting (AGM) at 9:30 am today. All Resolutions, as set out in the Notice of Meeting dated 28 June 2024, were duly passed.
The table below shows the proxy position for all Resolutions:
| SS | FOR | AGAINST | WITHHELD | ||
| | No. of Votes | % | No. of Votes | % | No. of Votes |
| Resolution 1 To receive and adopt the annual reports and accounts of the Company for the year ended 31 December 2023 together with the Directors' reports and auditor's report on those accounts. (Ordinary Resolution) | 165,058,060 | 100.00% | 0 | 0.00% | 1,836 |
| Resolution 2 | 138,296,789 | 85.03% | 24,355,057 | 14.97% | 2,408,050 |
| Resolution 3 | 164,853,946 | 99.88% | 202,489 | 0.12% | 3,461 |
| Resolution 4 | 164,856,234 | 99.88% | 199,842 | 0.12% | 3,820 |
| Resolution 5 | 164,893,187 | 99.90% | 164,889 | 0.10% | 1,820 |
| Resolution 6 | 164,992,717 | 99.96% | 63,718 | 0.04% | 3,461 |
| Resolution 7 | 164,893,546 | 99.90% | 164,889 | 0.10% | 1,461 |
| Resolution 8 | 164,495,975 | 99.66% | 562,396 | 0.34% | 1,525 |
| Resolution 9 | 165,027,622 | 99.98% | 28,013 | 0.02% | 4,261 |
| Resolution 10 To authorise the directors to allot shares up to the limits set out in the notice of meeting. (Ordinary Resolution) | 164,950,862 | 99.96% | 71,610 | 0.04% | 37,424 |
| Resolution 11 That subject to the passing of resolution 10, the Directors be authorised to allot equity securities for cash on a non-pre-emptive basis. (Special Resolution) | 164,949,225 | 99.96% | 73,247 | 0.04% | 37,424 |
| Resolution 12 That, subject to the passing of resolution 10, the Directors be authorised to allot equity securities for cash for and acquisitions or specified capital investment. (Special Resolution) | 164,946,809 | 99.95% | 75,663 | 0.05% | 37,424 |
Note: the 'For' votes include those giving the Chairman discretion.
Note: the full text of each of the resolutions is contained in the Notice of Annual General Meeting which is available on the Company's website at https://www.sisplc.com/results‐centre/.
For further information:
Science in Sport plc T: 020 7400 3700
Dan Wright, Executive Chairman
Chris Welsh, CFO
Panmure Liberum Limited (Nominated Adviser and Broker) T: 020 3100 2000
Richard Lindley
John More
Notes to Editors
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and ebay, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market.
PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart.
SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA.
SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs.
For further information, please visit phd.com and scienceinsport.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.